Navigation Links
Sanofi Aventis: Study Shows Otamixaban Substantially Reduced Complications of Invasive Management of Acute Coronary Syndromes
Date:8/31/2009

PARIS, August 31 /PRNewswire-FirstCall/ --

- SEPIA-ACS Multiple-Dose Phase II Results Showing 27- 42% Risk Reduction in ACS Complications Presented in Plenary Session of European Society of Cardiology Congress and Published in The Lancet -

Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today that the investigational anti-Xa intravenous anticoagulant otamixaban reduced by 27 to 42 percent the odds of the composite primary endpoint of death, myocardial infarction, urgent revascularization or rescue GPIIb/IIIa use in 4 out of the 5 otamixaban tested doses, versus standard UFH/eptifibatide combination in [non-ST] ACS patients suitable for invasive strategy. The results of the SEPIA-ACS1/ TIMI-42 were presented today at the plenary session of the Annual European Society of Cardiology congress in Barcelona and simultaneously published online in The Lancet.

Otamixaban is a first in class, rapid onset antithrombotic compound, acting as a direct selective inhibitor of factor Xa. Otamixaban is originating from sanofi-aventis world-class thrombosis research portfolio and is currently in phase IIb clinical development phase.

"The data show that intermediate dosages of otamixaban may offer substantial reduction in major coronary complications in patients presenting with acute coronary syndrome, with bleeding rate comparable to current therapy," said Dr Marc Sabatine, MD, MPH, an Investigator in the TIMI Study Group and a cardiologist at Brigham and Women's Hospital, Harvard Medical School. "This research is addressing an important medical need, by potentially significantly improving outcomes of ACS patients undergoing PCI while simplifying the treatment pattern of the acute management phase of the disease," he added.

The double-blind phase
'/>"/>

SOURCE Sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
2. Sanofi-aventis Stands Behind the Safety of Lantus(R)
3. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
4. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
5. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
6. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
7. Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US
8. Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile
9. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
10. Sanofi Pasteur Receives FDA Approval of Meningococcal Vaccine for Children
11. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... 7. Juli 2015 BioClinica®, Inc ... klinische Studien, gab heute bekannt, dass es mit ... bei Gewinnung und Erhalt von Patienten übernommen hat. ... MediciGlobal , Ltd. und Access to Patients, LLC. ... Dienst zum Auffinden von Patienten, die für die ...
(Date:7/7/2015)... 7, 2015   InspireMD, Inc. (NYSE ... in embolic protection systems ("EPS"), today announced that ... integrated with MicroNet ™ has received the ... Product Innovation Award.  Through active market research efforts, ... consultants recognize the successful introduction of new and ...
(Date:7/7/2015)... -- Essentialis, a venture-backed company focused on the development of K ... and metabolic diseases, today announced that Dr. Neil M. ... at the Cantor Fitzgerald Inaugural Healthcare Conference. ... 8, 2015 Time: 8:00 AM Eastern Time Location: ... Essentialis is a Carlsbad ...
Breaking Medicine Technology:BioClinica übernimmt MediciGroup 2BioClinica übernimmt MediciGroup 3BioClinica übernimmt MediciGroup 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 2InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 3InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 4InspireMD Receives Frost & Sullivan 2015 European Coronary Stent New Product Innovation Award 5
... NEW YORK, Jan. 13, 2012  The New Year brings hope ... Society (ACS) predicts another 240,000 U.S. men will receive this ... battle we are winning. Prostate cancer -specific deaths dropped ... PSA screening and improved surgical treatment, in the form ...
... 2012 The U.S. Food and Drug Administration today ... by W.L. Gore and Associates Inc. to include treatment ... aortic transection). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... endovascular graft approved by the FDA to treat a ...
Cached Medicine Technology:PSA Testing and Robotic Surgery Take on Prostate Cancer 2PSA Testing and Robotic Surgery Take on Prostate Cancer 3FDA Expands Use of Endovascular Graft to Treat Aortic Tears 2
(Date:7/7/2015)... PHOENIX, (PRWEB) , ... July ... ... Western Refining convenience stores throughout the Southwest, including Giant, Mustang, Sun Dial ... camp mobile program, surpassing their original 2015 fundraising goal by nearly $100,000, ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... rumors about possible facial rejuvenation that have emerged about Hillary Clinton. Two plastic ... of State looks more youthful than she has in some time and speculate ...
(Date:7/7/2015)... ... ... Quadrino Law Group is pleased to announce the relocation of the firm's headquarters to ... is a state of the art building, located with easy access to New York ... said, "We are pleased to service our clients from such a premier location and ...
(Date:7/7/2015)... , ... July 07, 2015 , ... Safe Catch is ... single fish for mercury. Albertsons, Gelson’s Markets, New Leaf Community Markets, Sprouts Farmers Market ... , “We developed the technology to test every fish for mercury,” said Safe Catch ...
(Date:7/7/2015)... ... July 07, 2015 , ... Parents and guardians of ... A Forever Recovery, an open-ended holistic treatment center for drug and alcohol abuse located ... Use and HIV Research has shown a significant increase in the “club drug” use ...
Breaking Medicine News(10 mins):Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 2Health News:Western Refining Raises $524,286 to Help Send Kids with Neuromuscular Disease to MDA Summer Camp 3Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 2Health News:Recent Article on Hillary Clinton Plastic Surgery Speculation Illuminates the Reasons Many Professionals Explore Facial Rejuvenation, says Dr. J 3Health News:Safe Catch Launches Tuna with Lowest Mercury Limit of Any Brand 2Health News:A Forever Recovery Releases New Information on “Club Drugs” and Tips for Parents of Teens and Young Adults 2
... team of researchers led by an Indian American scientist ... source of nutrition. // ,Cotton fibre continues to ... are a high source of protein, but the presence ... human consumption. ,To remove gossypol from cottonseeds, ...
... Centre at Canada's University //of British Columbia conducted a ... Alzheimer’s disease. , ,During the study, the researchers ... low-oxygen levels for about 16 hours a day, which ... normal levels of oxygen. ,After a month ...
... report that might alert the antennae of call centre employees, ... nearly two-thirds of call // centers in UK, who are ... to prevent hearing damage in their employees. This revelation is ... centre employees, who are undoubtedly risking an important faculty of ...
... ago this month, German psychiatrist Alois Alzheimer formally ... came to bear his name. While international efforts ... have progressed significantly in recent years, a cure ... research tool developed by Susan Liebman, distinguished university ...
... the obese children, to undergo weight loss surgery. //To implement ... that NHS offers the expensive weight loss surgery, free of ... Excellence (NICE), which is presently embroiled in the Alzheimer’s drugs ... treatment plan, targeting obesity in adults and children. ...
... HIV-infected children in South Kazakhstan has reached 80 with the ... – said the officials and non-governmental groups. It is believed ... which caused the death. ,Chief physician of the ... the press persons on Monday that a child infected with ...
Cached Medicine News:Health News:Yeast Model Shows Promise as Alzheimer's Test 2
Penicillin G (1 x 10 4 units/mL and Streptomycin (10mg/mL) Solution. 100X Concentrate....
... 25,000 units Penicillin/25,000 ... Cell Culture Reagent and ... in accordance with cGMP ... culture tested to assure ...
... (Penicillin G) inhibits bacterial ... synthesis. Streptomycin belongs to ... inhibits bacterial growth by ... is used for prevention ...
... A combination of penicillin and streptomycin ... positive and gram negative bacteria when ... 100,000 I.U. Penicillin/100,000 g/mL Streptomycin per ... in water at concentrations of 5,000 ...
Medicine Products: